Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: A joint study from five nordic countries

Journal of Medical Genetics

Volumn 50, Issue 6, 2013, Pages 373-382

  Fallah, Mahdi ^a   Pukkala, Eero ^b,c   Tryggvadottir, Laufey ^d,e   Olsen, Jörgen H ^f   Tretli, Steinar ^g   Sundquist, Kristina ^h   Hemminki, Kari ^a,h  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b FINNISH CANCER REGISTRY   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d ICELANDIC CANCER REGISTRY   (Iceland)

^e UNIVERSITY OF ICELAND   (Iceland)

^f INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^g CANCER REGISTRY OF NORWAY   (Norway)

^h LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANAPLASTIC THYROID CANCER; ARTICLE; CALCULATION; CANCER DIAGNOSIS; CANCER GENETICS; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; FEMALE; FINLAND; FIRST DEGREE RELATIVE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ICELAND; INFANT; MAJOR CLINICAL STUDY; MALE; NORWAY; ONCOCYTOMA; POPULATION BASED CASE CONTROL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX RATIO; STANDARDIZED INCIDENCE RATIO; SWEDEN; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TREND STUDY;

CUMULATIVE RISK; FAMILIAL RISK; NON-MEDULLARY THYROID CARCINOMA; NORDIC COUNTRIES; THYROID CANCER;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FAMILY; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RISK; SCANDINAVIA; SEX FACTORS; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84878871240     PISSN: 00222593     EISSN: 14686244     Source Type: Journal    
DOI: 10.1136/jmedgenet-2012-101412     Document Type: Article

References (44)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer, 2010.
2. Khan A, Smellie J, Nutting C, Harrington K, Newbold K. Familial nonmedullary thyroid cancer: a review of the genetics. Thyroid 2010;20:795-801.
3. Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse S, Kosary C, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner M, Lewis D, Chen H, Feuer E, Cronin K, Edwards B. SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute, 2011.
4. Pacini F, Castagna MG, Cipri C, Schlumberger M. Medullary thyroid carcinoma. Clin Oncol (R Coll Radiol) 2010;22:475-85.
5. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see comments]. Cancer 1998;83:2638-48.
6. Boyle P, Levin B. World Cancer Report 2008. Lyon: International Agency for Research on Cancer (IARC), 2008.
7. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-8.
8. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, Sulem P, Kristjansson K, Arnason S, Gulcher JR, Bjornsson J, Kong A, Thorsteinsdottir U, Stefansson K. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004;1:e65.
9. Negri E, Ron E, Franceschi S, La Vecchia C, Preston-Martin S, Kolonel L, Kleinerman RA, Mabuchi K, Jin F, Wingren G, Hallquist A, Levi F, Linos A, Fraumeni JF Jr. Risk factors for medullary thyroid carcinoma: a pooled analysis. Cancer Causes Control 2002;13:365-72.
10. Hemminki K, Dong C. Population-based study of familial medullary thyroid cancer. Fam Cancer 2001;1:45-9.
11. Hemminki K, Dong C. Familial relationships in thyroid cancer by histo-pathological type. Int J Cancer 2000;85:201-5.
12. Mazeh H, Benavidez J, Poehls JL, Youngwirth L, Chen H, Sippel RS. In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease. Thyroid 2012;22:3-8.
13. Nose V. Familial follicular cell tumors: classification and morphological characteristics. Endocr Pathol 2010;21:219-26.
14. Hanief MR, Igali L, Grama D. Hurthle cell carcinoma: diagnostic and therapeutic implications. World J Surg Oncol 2004;2:27.
15. Chiacchio S, Lorenzoni A, Boni G, Rubello D, Elisei R, Mariani G. Anaplastic thyroid cancer: prevalence, diagnosis and treatment. Minerva Endocrinol 2008;33:341-57.
16. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment. J Oncol 2011;2011:542358.
17. Giuffrida D, Gharib H. Anaplastic thyroid carcinoma: current diagnosis and treatment. Ann Oncol 2000;11:1083-9.
18. Syed MI, Stewart M, Syed S, Dahill S, Adams C, McLellan DR, Clark LJ. Squamous cell carcinoma of the thyroid gland: primary or secondary disease?. J Laryngol Otol 2011;125:3-9.
19. Hemminki K, Eng C, Chen B. Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab 2005;90:5747-53.
20. Frich L, Glattre E, Akslen LA. Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5673 first-degree relatives of thyroid cancer patients from Norway. Cancer Epidemiol Biomarkers Prev 2001;10:113-17.
21. Galanti MR, Ekbom A, Grimelius L, Yuen J. Parental cancer and risk of papillary and follicular thyroid carcinoma. Br J Cancer 1997;75:451-6.
22. Brindel P, Doyon F, Bourgain C, Rachedi F, Boissin JL, Sebbag J, Shan L, Bost-Bezeaud F, Petitdidier P, Paoaafaite J, Teuri J, de Vathaire F. Family history of thyroid cancer and the risk of differentiated thyroid cancer in French polynesia. Thyroid 2010;20:393-400.
23. Mack WJ, Preston-Martin S, Bernstein L, Qian D. Lifestyle and other risk factors for thyroid cancer in Los Angeles County females. Ann Epidemiol 2002;12:395-401.
24. Memon A, Berrington De Gonzalez A, Luqmani Y, Suresh A. Family history of benign thyroid disease and cancer and risk of thyroid cancer. Eur J Cancer 2004;40:754-60.
25. Pal T, Vogl FD, Chappuis PO, Tsang R, Brierley J, Renard H, Sanders K, Kantemiroff T, Bagha S, Goldgar DE, Narod SA, Foulkes WD. Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab 2001;86:5307-12.
26. Ron E, Kleinerman RA, Boice JD Jr., LiVolsi VA, Flannery JT, Fraumeni JF Jr. A population-based case-control study of thyroid cancer. J Natl Cancer Inst 1987;79:1-12.
27. Xu L, Li G, Wei Q, El-Naggar AK, Sturgis EM. Family history of cancer and risk of sporadic differentiated thyroid carcinoma. Cancer 2012;118:1228-35.
28. Vlajinac HD, Adanja BJ, Zivaljevic VR, Jankovic RR, Dzodic RR, Jovanovic DD. Malignant tumors in families of thyroid cancer patients. Acta Oncol 1997;36:477-81.
29. Storm HH. Survey of Nordic Cancer Registries. Copenhagen: Danish Cancer Society, 2000.
30. Lund EM, Clemmensen IH, Storm HH, Engholm G. Survey of the Nordic Cancer Registries. Danish Cancer Society, Copenhagen, 2000.
31. Lappalainen T, Hannelius U, Salmela E, von Dobeln U, Lindgren CM, Huoponen K, Savontaus ML, Kere J, Lahermo P. Population structure in contemporary Sweden-a Y-chromosomal and mitochondrial DNA analysis. Ann Hum Genet 2009;73:61-73.
32. Lao O, Lu TT, Nothnagel M, Junge O, Freitag-Wolf S, Caliebe A, Balascakova M, Bertranpetit J, Bindoff LA, Comas D, Holmlund G, Kouvatsi A, Macek M, Mollet I, Parson W, Palo J, Ploski R, Sajantila A, Tagliabracci A, Gether U, Werge T, Rivadeneira F, Hofman A, Uitterlinden AG, Gieger C, Wichmann HE, Ruther A, Schreiber S, Becker C, Nurnberg P, Nelson MR, Krawczak M, Kayser M. Correlation between genetic and geographic structure in Europe. Curr Biol 2008;18:1241-8.
33. Nelis M, Esko T, Magi R, Zimprich F, Zimprich A, Toncheva D, Karachanak S, Piskackova T, Balascak I, Peltonen L, Jakkula E, Rehnstrom K, Lathrop M, Heath S, Galan P, Schreiber S, Meitinger T, Pfeufer A, Wichmann HE, Melegh B, Polgar N, Toniolo D, Gasparini P, D'Adamo P, Klovins J, Nikitina-Zake L, Kucinskas V, Kasnauskiene J, Lubinski J, Debniak T, Limborska S, Khrunin A, Estivill X, Rabionet R, Marsal S, Julia A, Antonarakis SE, Deutsch S, Borel C, Attar H, Gagnebin M, Macek M, Krawczak M, Remm M, Metspalu A. Genetic structure of Europeans: a view from the North-East. PLoS One 2009;4:e5472.
34. Kharazmi E, Fallah M, Sundquist K, Hemminki K. Familial risk of early and late onset cancer: nationwide prospective cohort study. BMJ 2012;345:e8076.
35. Rosario PW, Mineiro Filho AF, Prates BS, Silva LC, Lacerda RX, Calsolari MR. Ultrasonographic screening for thyroid cancer in siblings of patients with apparently sporadic papillary carcinoma. Thyroid 2012;22:805-8.
36. Nose V. Familial thyroid cancer: a review. Mod Pathol 2011;24(Suppl 2):S19-33.
37. Na KY, Kim RM, Song EM, Lee JH, Lee J, Soh EY. Allelic loss of susceptibility loci and the occurrence of BRAF and RAS mutations in patients with familial non-medullary thyroid cancer. J Surg Oncol 2012;105:10-14.
38. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 2009;41:460-4.
39. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Masson G, He H, Jonasdottir A, Sigurdsson A, Stacey SN, Johannsdottir H, Th Helgadottir H, Li W, Nagy R, Ringel MD, Kloos RT, de Visser MC, Plantinga TS, den Heijer M, Aguillo E, Panadero A, Prats E, Garcia-Castano A, De Juan A, Rivera F, Walters GB, Bjarnason H, Tryggvadottir L, Eyjolfsson GI, Bjornsdottir US, Holm H, Olafsson I, Kristjansson K, Kristvinsson H, O TM, Thorleifsson G, Gulcher JR, Kong A, Kiemeney LA, Jonsson T, Hjartarson H, Mayordomo JI, Netea-Maier RT, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Rafnar T, Stefansson K. Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet 2012;44:319-22.
40. He H, Nagy R, Liyanarachchi S, Jiao H, Li W, Suster S, Kere J, de la Chapelle A. A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res 2009;69:625-31.
41. Fusco A, Viglietto G, Santoro M. Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas. Br J Cancer 2005;92:1817-18.
42. Maximo V, Botelho T, Capela J, Soares P, Lima J, Taveira A, Amaro T, Barbosa AP, Preto A, Harach HR, Williams D, Sobrinho-Simoes M. Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer 2005;92:1892-8.
43. Fagin JA, Mitsiades N. Molecular pathology of thyroid cancer: diagnostic and clinical implications. Best Pract Res Clin Endocrinol Metab 2008;22:955-69.
44. Weires M, Bermejo JL, Sundquist J, Hemminki K. Clustering of concordant and discordant cancer types in Swedish couples is rare. Eur J Cancer 2011;47:98-106.